Rik Raes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Rik Raes has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Denis Chegodaev
Graduate School of Natural Science and Technology, Kanazawa University, Kanazawa 920-1192, Japan
1 shared publication - Kenji Satou
Affiliation Faculty of Transdisciplinary Sciences for Innovation, Institute of Transdisciplinary Sciences for Innovation, Kanazawa University, Kanazawa, Japan
1 shared publication - Lilies Handayani
Institute of Transdisciplinary Sciences for Innovation, Kanazawa University, Kanazawa 920-1192, Japan
1 shared publication - Thanawat Tangpornpisit
Graduate School of Natural Science and Technology, Kanazawa University, Kanazawa, Japan
1 shared publication
Latest Publications
- Open Access
- 8 November 2024
- Published by Association for Computing Machinery (ACM)
- p. 236-241
Identification of Key Gene Modules in Triple Negative Breast Cancer Cells Treated using Weighted Gene Co-Expression Network Analysis
Triple negative breast cancer (TNBC) presents substantial challenges in clinical oncology because of its aggressive characteristics and fewer treatment options relative to other breast cancer subtypes. Understanding the molecular mechanisms underlying TNBC response to therapy-induced senescence-derived small extracellular vesicles (sEVs) is crucial for improving treatment outcomes. In this study, we employed weighted gene co-expression network analysis (WGCNA) and gene ontology enrichment analysis (GOEA) to identify key gene modules and functional pathways associated with TNBC cell response to sEV treatments. Utilizing gene expression data from MDA-MB-231 cells treated with three types of sEVs (No sEV, Cont sEV, TIS sEV), we identified two modules exhibiting significant correlations with treatment conditions. Genes within these modules, such as Sema3g, Hoxc8, Fgf8, Myb, Clusterin, Trim28, and Arf1, were found to play crucial roles in modulating TNBC cell response to sEVs through various molecular mechanisms. GOEA revealed their involvement in biological processes such as mitochondrial function, respiratory processes, membrane transport, and oxidoreduction activities. This study provides insights into the complex molecular mechanisms underlying TNBC response to sEV treatments and lays the groundwork for developing targeted therapies to enhance treatment effectiveness in TNBC.
- 8 November 2024
- Published by Association for Computing Machinery (ACM)
- p. 236-241
Open AccessIdentification of Key Gene Modules in Triple Negative Breast Cancer Cells Treated using Weighted Gene Co-Expression Network Analysis
Triple negative breast cancer (TNBC) presents substantial challenges in clinical oncology because of its aggressive characteristics and fewer treatment options relative to other breast cancer subtypes. Understanding the molecular mechanisms underlying TNBC response to therapy-induced senescence-derived small extracellular vesicles (sEVs) is crucial for improving treatment outcomes. In this study, we employed weighted gene co-expression network analysis (WGCNA) and gene ontology enrichment analysis (GOEA) to identify key gene modules and functional pathways associated with TNBC cell response to sEV treatments. Utilizing gene expression data from MDA-MB-231 cells treated with three types of sEVs (No sEV, Cont sEV, TIS sEV), we identified two modules exhibiting significant correlations with treatment conditions. Genes within these modules, such as Sema3g, Hoxc8, Fgf8, Myb, Clusterin, Trim28, and Arf1, were found to play crucial roles in modulating TNBC cell response to sEVs through various molecular mechanisms. GOEA revealed their involvement in biological processes such as mitochondrial function, respiratory processes, membrane transport, and oxidoreduction activities. This study provides insights into the complex molecular mechanisms underlying TNBC response to sEV treatments and lays the groundwork for developing targeted therapies to enhance treatment effectiveness in TNBC.